Stanley D. Chamberlain

Author

Also Known As

Chamberlain, S. D., S. Chamberlain, S. D. CHAMBERLAIN, S. D. Chamberlain, S.D Chamberlain, Stanley Chamberlain, Stanley D. Chamberlain

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Research Triangle Park Foundation GlaxoSmithKline (United States)Senex Biotechnology (United States)Cardiff University University of Michigan

About

Stanley D. Chamberlain is an author at Research Triangle Park Foundation specializing in medicine, drug discovery, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	19	758
2	Natural Sciences	15	17	642
3	Engineering	5	5	208
4	Arts	1	1	27
5	Health Sciences	1	1	31

Stanley D. Chamberlain

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Inhibition of colony-stimulating-factor-1 signaling<i>in vivo</i>with the orally bioavailable cFMS kinase inhibitor GW2580 James G. Conway, Brad McDonald, Janet H. Parham, Proceedings of the National Academy of Sciences	2005	252
Design, Synthesis, and Antiviral Activity of α-Nucleosides: <scp>d</scp>- and <scp>l</scp>-Isomers of Lyxofuranosyl- and (5-Deoxylyxofuranosyl)benzimidazoles Michael T. Migawa, Jean‐Luc Girardet, John Walker, Journal of Medicinal Chemistry	1998	211
Design, synthesis and evaluation of a novel double pro-drug: INX-08189. A new clinical candidate for hepatitis C virus Christopher McGuigan, Karolina Madela, Mohamed Aljarah, Bioorganic & Medicinal Chemistry Letters HepatologyHepatitis C VirusViral HepatitisMedicineNovel Double Pro-drug	2010	99
GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers Peter Sabbatini, Susan Korenchuk, Jason L. Rowand, Molecular Cancer Therapeutics Antitumor ActivityImmunologyGlucose HomeostasisExperimental ModelsInsulin Receptor	2009	98
Pyrazolo[1,5-a]pyridines as p38 Kinase Inhibitors Kirk L. Stevens, David Jung, Michael J. Alberti, Organic Letters Medicinal ChemistryHeterocyclicP38 Kinase InhibitorsBiochemistryMedicine	2005	87
INX-08189, a Phosphoramidate Prodrug of 6-<i>O</i>-Methyl-2′-<i>C</i>-Methyl Guanosine, Is a Potent Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic and Pharmacodynamic Properties John Vernachio, Blair Bleiman, K. Dawn Bryant, Antimicrobial Agents and Chemotherapy	2011	84
New methodologies for the synthesis of C-2 functionalized hypoxanthine nucleosides Vasu Nair, Gregory A. Turner, Greg S. Buenger, The Journal of Organic Chemistry Novel OrganocatalystsMolecular SciencesEngineeringChemical MeasurementBiochemistry	1988	65
Novel approaches to functionalized nucleosides via palladium-catalyzed cross coupling with organostannanes Vasu Nair, Gregory A. Turner, Stanley D. Chamberlain Journal of the American Chemical Society Cross-coupling ReactionMolecular SciencesEngineeringChemical AnalysisBiochemistry	1987	62
Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein binding Kyle A. Emmitte, George M. Adjebang, C. Webb Andrews, Bioorganic & Medicinal Chemistry Letters BiochemistryMedicineNatural SciencesReceptor Tyrosine KinaseProtein Phosphorylation	2009	61
Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity Stanley D. Chamberlain, Anikó M. Redman, Joseph W. Wilson, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryNatural SciencesMedicineReceptor Tyrosine Kinase	2008	57

Page 1